A consequence of the activation of the EMT process in tumor cells is the acquisition of invasive and metastatic properties, due to the inhibition of E-cadherin expression and increased expression of mesenchymal markers such as vimentin and Twist (Sun et al., 2020). The gene discussed is TWIST1; the disease is neoplasm.